The authors reply

New England Journal of Medicine

Volumn 363, Issue 7, 2010, Pages 697-

  Cushman, William C ^a   Simons Morton, Denise G ^b   Cutler, Jeffrey G ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ARTERIAL STIFFNESS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTHESIS; INTENSIVE CARE; KIDNEY FAILURE; LETTER; MICROVASCULARIZATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; SAMPLE SIZE; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 77957284261     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol 2009;54:1827-34.
2. The Eighth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 8). Bethesda, MD: National Heart, Lung, and Blood Institute. (Accessed July 22, 2010, at http://www.nhlbi.nih.gov/guidelines/hypertension/jnc8/index.htm.)
3. Schrier RW, Estacio RO, Mehler PS, Hiatt WR. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Clin Pract Nephrol 2007;3:428-38.
4. The ACCORD Study Group and ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010;363:233-44.